Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt investors to reassess its current ...

Nvidia's positions in these companies were relatively small at the end of the third quarter of 2025, but the chipmaker has spent recent years building a portfolio of AI‑related investments across ...

A developer-targeting campaign leveraged malicious Next.js repositories to trigger a covert RCE-to-C2 chain through standard ...

After eight episodes of post-apocalypse insanity and plenty of irradiated creatures, Fallout wrapped up Season 2 with the season finale, “The Strip,” this week. Given that multiple characters are left ...

Vercel has launched "react-best-practices," an open-source repository featuring 40+ performance optimization rules for React and Next.js apps. Tailored for AI coding agents yet valuable for developers ...

Learn how car loans work and how to find the best one for you Betsy began her career in international finance and it has since grown into a comprehensive approach to journalism as she's been able to ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...